Volume 21, Issue 5 p. 647-651

Seizure Activity and Unresponsiveness after Hydroxycut Ingestion

Dr. Denise R. Kockler Pharm.D.

Corresponding Author

Dr. Denise R. Kockler Pharm.D.

Department of Pharmacy Services, Drug Information Center, University of Virginia Health System, Charlottesville, Virginia

Department of Pharmacy Services, University of Virginia Health System, P.O. Box 800674, Charlottesville, VA 22908-0674Search for more papers by this author
Dr. Michelle W. McCarthy Pharm.D.

Dr. Michelle W. McCarthy Pharm.D.

Department of Pharmacy Services, Drug Information Center, University of Virginia Health System, Charlottesville, Virginia

Search for more papers by this author
Dr. Cathy L. Lawson Pharm.D.

Dr. Cathy L. Lawson Pharm.D.

CVS/Pharmacy, Woonsocket, Rhode Island

Search for more papers by this author
First published: 17 January 2012
Citations: 29

Abstract

A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates, acetaminophen, alcohol, and drugs of abuse. Medical history was insignificant with the exception of recent (within 2 wks) ingestion of Hydroxycut, a dietary supplement purported to be energy enhancing, muscle building, and fat burning. The agent contains ephedra alkaloids and caffeine, which are both central nervous system stimulants; the etiology of seizure was attributed to their consumption. Due to a significant number of reported adverse events, the United States Food and Drug Administration (FDA) proposed regulations for dietary supplements containing ephedra alkaloids and requested an independent review of case reports linked to these products. Because herbal products are not subject to the same rigorous FDA regulations required for prescription and over-the-counter products, consumers unknowingly risk adverse effects when taking these products. Questioning patients about consumption of herbal products should be part of routine medical visits.